Apeiron Investment Group Ltd., Ten Percent Owner at ATAI Life Sciences, holds 42.35M shares in ATAI Life Sciences (Ticker: ATAI), holds 276.49M shares in Neuphoria Therapeutics (Ticker: NEUP), holds 926.54K shares in Alto Neuroscience, Inc. (Ticker: ANRO). Most recently, Apeiron Investment Group Ltd. Bought ― shares of ATAI Life Sciences on Feb 19, 2025 for an estimated value of 22.76M.
What is the percentage of profitable transactions made by Apeiron Investment Group Ltd.?
The percentage of profitable transactions made by Apeiron Investment Group Ltd. is 14%.
What is the average return per transaction made by Apeiron Investment Group Ltd.?
The average return per transaction made by Apeiron Investment Group Ltd. is -42.00%.
What stocks does Apeiron Investment Group Ltd. hold?
Apeiron Investment Group Ltd. holds: ATAI, SNSE, ANRO, NEUP stocks.
What was Apeiron Investment Group Ltd.’s latest transaction?
Apeiron Investment Group Ltd. latest transaction was an Informative Buy of $22.76M.
What was Apeiron Investment Group Ltd.'s most profitable transaction?
Apeiron Investment Group Ltd.’s most profitable transaction was an Informative Sell of SNSE stock on June 2, 2023. The return on the trade was 47.50%.
What is Apeiron Investment Group Ltd.'s role in ATAI Life Sciences?
Apeiron Investment Group Ltd.'s role in ATAI Life Sciences is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.